@Davisite is it possible to run a small cohort using RC110 under the NPP in France (given Bisantrene is approved there) to test run cardioprotect and FTO before we blow a lot of cash on P1 and P2, to provide proof of concept in the clinic? Assuming RC110 and RC220 would also be considered a new drug from the perspective in France?
Maybe its as simple as RC110 NPP volunteers + hire a trendmill in france : )
Natural cardio protective
Cardioprotective Activity of Randia Dumetorum Against Doxorubicin Induced Cardiotoxicity – Biosciences Biotechnology Research Asia (biotech-asia.org)
General Comments / Chat, page-10405
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.095(7.22%) |
Mkt cap ! $234.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.41 | $1.32 | $249.8K | 182.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2826 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 40000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.37 |
Change
0.095 ( 6.64 %) |
||||
| Open | High | Low | Volume | ||
| $1.34 | $1.41 | $1.32 | 16145 | ||
| Last updated 15.53pm 10/05/2024 ? | |||||
| RAC (ASX) Chart |